Literature DB >> 9579803

Determination of glycan structures and molecular masses of the glycovariants of serum transferrin from a patient with carbohydrate deficient syndrome type II.

B Coddeville1, H Carchon, J Jaeken, G Briand, G Spik.   

Abstract

Serum transferrin from a child with carbohydrate deficient syndrome type II was isolated by immunoaffinity chromatography and separated into minor and major fractions by fast protein liquid chromatography. The structure of the glycans released from the major fraction by hydrazinolysis was established by application of methanolysis and 1H-NMR spectroscopy. The results led to the identification of an N-acetyllactosamininic type monosialylated, monoantennary Man(alpha1-3) linked glycan. By electrospray-mass spectrometry analysis, the whole serum transferrin was separated into at least seven species (I to VII) with molecular masses ranging from 77,958 to 79,130 Da. On the basis of a polypeptide chain molecular mass of 75,143 Da, it was calculated that the major transferrin species III (78,247 Da) contains two monosialylated monoantennary glycans. The molecular mass of transferrin species V and VI (78,678 and 78,971 Da) suggests that one of their two glycans contains an additional N-acetyllactosamine and a sialylated N-acetyllactosamine units, respectively. Transferrin species I and V were found to correspond to the desialylated forms of species III and VI. The abnormal glycan structures can be explained by a defect in the N-acetylglucosaminyltransferase II activity [Charuk et al. (1995) Eur J Biochem 230: 797-805].

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579803     DOI: 10.1023/a:1006997012617

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  44 in total

1.  Clinical significance of abnormal heterogeneity of transferrin in relation to alcohol consumption.

Authors:  H Stibler; S Borg; C Allgulander
Journal:  Acta Med Scand       Date:  1979

2.  Carbohydrate composition of serum transferrin in alcoholic patients.

Authors:  H Stibler; S Borg
Journal:  Alcohol Clin Exp Res       Date:  1986 Jan-Feb       Impact factor: 3.455

Review 3.  Carbohydrate-deficient glycoprotein syndromes: peculiar group of new disorders.

Authors:  B A Hagberg; G Blennow; B Kristiansson; H Stibler
Journal:  Pediatr Neurol       Date:  1993 Jul-Aug       Impact factor: 3.372

4.  The structure of the asialo-carbohydrate units of human serotransferrin as proven by 360 MHz proton magnetic resonance spectroscopy.

Authors:  L Dorland; J Haverkamp; B L Schut; J F Vliegenthart
Journal:  FEBS Lett       Date:  1977-05-01       Impact factor: 4.124

5.  Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II caused by a defect in the gene encoding alpha-mannosidase II.

Authors:  M N Fukuda; K A Masri; A Dell; L Luzzatto; K W Moremen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

6.  The structural heterogeneity of the carbohydrate moiety of desialylated human transferrin.

Authors:  L März; M W Hatton; L R Berry; E Regoeczi
Journal:  Can J Biochem       Date:  1982-06

7.  N-glycosylation site mapping of human serotransferrin by serial lectin affinity chromatography, fast atom bombardment-mass spectrometry, and 1H nuclear magnetic resonance spectroscopy.

Authors:  D Fu; H van Halbeek
Journal:  Anal Biochem       Date:  1992-10       Impact factor: 3.365

8.  Primary defect of congenital dyserythropoietic anemia type II. Failure in glycosylation of erythrocyte lactosaminoglycan proteins caused by lowered N-acetylglucosaminyltransferase II.

Authors:  M N Fukuda; A Dell; P Scartezzini
Journal:  J Biol Chem       Date:  1987-05-25       Impact factor: 5.157

9.  Carbohydrate-deficient glycoprotein syndrome type II. An autosomal recessive N-acetylglucosaminyltransferase II deficiency different from typical hereditary erythroblastic multinuclearity, with a positive acidified-serum lysis test (HEMPAS).

Authors:  J H Charuk; J Tan; M Bernardini; S Haddad; R A Reithmeier; J Jaeken; H Schachter
Journal:  Eur J Biochem       Date:  1995-06-01

10.  The primary structure of human serum transferrin. The structures of seven cyanogen bromide fragments and the assembly of the complete structure.

Authors:  R T MacGillivray; E Mendez; J G Shewale; S K Sinha; J Lineback-Zins; K Brew
Journal:  J Biol Chem       Date:  1983-03-25       Impact factor: 5.157

View more
  7 in total

1.  Characterization of Transferrin Glycopeptide Structures in Human Cerebrospinal Fluid.

Authors:  Kristy J Brown; Adeline Vanderver; Eric P Hoffman; Raphael Schiffmann; Yetrib Hathout
Journal:  Int J Mass Spectrom       Date:  2012-02-15       Impact factor: 1.986

Review 2.  Mass spectrometric analysis of glycans in elucidating the pathogenesis of CDG type IIx .

Authors:  P B Mills; K Mills; N Mian; B G Winchester; P T Clayton
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

3.  Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie)

Authors:  S Kim; V Westphal; G Srikrishna; D P Mehta; S Peterson; J Filiano; P S Karnes; M C Patterson; H H Freeze
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

Review 4.  The joys of HexNAc. The synthesis and function of N- and O-glycan branches.

Authors:  H Schachter
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

Review 5.  The impact of mass spectrometry in the diagnosis of congenital disorders of glycosylation.

Authors:  Luisa Sturiale; Rita Barone; Domenico Garozzo
Journal:  J Inherit Metab Dis       Date:  2011-03-08       Impact factor: 4.982

6.  Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry to Detect Diagnostic Glycopeptide Markers of Congenital Disorders of Glycosylation.

Authors:  Yoshinao Wada
Journal:  Mass Spectrom (Tokyo)       Date:  2020-04-23

7.  Discovery of Serotransferrin Glycoforms: Novel Markers for Diagnosis of Liver Periductal Fibrosis and Prediction of Cholangiocarcinoma.

Authors:  Wassana Jamnongkan; Carlito B Lebrilla; Mariana Barboza; Anchalee Techasen; Watcharin Loilome; Paiboon Sithithaworn; Narong Khuntikeo; Chawalit Pairojkul; Nittaya Chamadol; Raynoo Thanan; Puangrat Yongvanit
Journal:  Biomolecules       Date:  2019-09-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.